파크시스템스
251,000KRWMarket close of 10/21 (Wed)
Up +0.40%+1,000KRWMarket close of 10/21 (Wed)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)247,500KRWDown -1.39%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 254,500
- High
- 259,000
- Low
- 248,500
- Day range
- Day range low 248,500 high 259,000, open 254,500, close 251,000, previous close 250,000
- Volume
- 2×10K shares
- 5.0B KRW 0.55× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
33%1-year close range 208,000 to 339,500 won, 33% up from the low
33% of the way up from the lowest close in 1 year (252 sessions) · -26.1% from the high
Usual range
Nothing unusual in the 6 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveusual range+0.40%+0.40%, 0.1× the usual (20-session average ±2.75%)That day +0.40% · usual ±2.75% · large-move threshold ±5.5%
- Trading valueusual range0.6×5.0B KRW, 0.6× the 20-session average0.55× the 20-session average · check threshold 3×
- Earningsusual range23.4B KRWOperating income over the last four quarters 23.4B KRW
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional-4.7B KRWusual range
- Data date10/21 (Wed)Market close
See the full check report
Same sector · 의료·정밀기기
Up +2.11%· 56 of 101 stocks up, preferred shares excluded · trading value 249.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 나노엔텍 | Close over the last 20 sessions +10.6% | Up +8.13% | 39.0B KRW |
| 케이씨텍 | Close over the last 20 sessions +38.5% | Up +9.89% | 31.4B KRW |
| 디아이 | Close over the last 20 sessions +20.2% | Up +5.63% | 24.2B KRW |
| 티에스이 | Close over the last 20 sessions +9.5% | Up +3.42% | 20.1B KRW |
| 레메디 | Close over the last 20 sessions -0.3% | Up +4.50% | 19.6B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 25 days
- Next data 10/23 (Fri) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.